Optimization of High-Density Fermentation Process and Analysis of Key Influencing Factors for Pichia pastoris Engineering Strains
Chapter 1 Overview of the Pichia pastoris Expression System
Pichia pastoris, a unicellular eukaryotic microorganism capable of growing on methanol as its sole carbon source, has shown significant advantages in the field of recombinant protein expression. This expression system combines the efficiency typical to prokaryotic systems with post-translational modification capabilities unique to eukaryotes, making it one of the most widely used eukaryotic expression platforms in biotechnology today.
The core advantages of the Pichia pastoris expression system are primarily reflected in several aspects: first, its genome exhibits high stability, allowing long-term maintenance of foreign gene traits; second, it has a rapid cell proliferation rate that can double every 2-4 hours under suitable conditions; furthermore, this system possesses strong protein secretion capabilities where certain recombinant proteins can reach industrial-grade levels up to 22g/L. Notably, Pichia pastoris does not produce endotoxins and has natural resistance to phage infections—these characteristics confer special value in biopharmaceuticals.
After over thirty years of development, the Pichia pastoris expression system has been successfully applied to produce more than 1000 types of foreign proteins across various fields including industrial enzyme preparations, vaccine development, and therapeutic proteins. The expressed products maintain the spatial structure and biological activity characteristic to native proteins which is particularly important for expressing complex proteins requiring precise three-dimensional structures.
1.1 Common Host Strains and Their Characteristics
The host strains for engineered Pichia pastoris mainly originate from targeted modifications made on wild-type yeast Y-11430. Currently common laboratory and industrial production strains include GS115, X-33, GS190, KM71 and SMD1165 among others; these strains each have distinct genetic backgrounds along with specific selection markers and metabolic characteristics.
GS115 was developed as an early His4 nutritional deficiency strain that requires screening on histidine-deficient media. X-33 retains wild-type prototrophic features without needing special nutrient additives making it more suitable for large-scale fermentation production. The KM71 strain lacks alcohol oxidase gene AOX1 locus showing a slow methanol utilization (MutS) phenotype which reduces toxic intermediate accumulation during methanol metabolism. The SMD1165 series strains additionally lack protease genes significantly lowering risks associated with recombinant protein degradation.
1.2 Design and Selection of Expression Vector Systems
Pichia pastoris expression vectors can be categorized into self-replicating type or integration type based on their replication properties. Due to self-replicating vectors being prone to loss during subculturing processes; chromosome-integrated vectors are predominantly utilized in practical applications ensuring stable integration into yeast genomes through homologous recombination thus guaranteeing long-term inheritance stability for foreign genes.
Based on protein secretion characteristics integrated vectors may further be divided into intracellular expression vectors (such as pPIC3、pPSC3K、pAO815 etc.) or secretory type expression vectors (like pPIC9、pPIC9K、pGAPZA etc.). Secretory type vectors typically carry α-mating factor signal peptide sequences guiding recombinant proteins' secretion into extracellular culture medium simplifying downstream purification processes while avoiding degradation by intracellular proteases.
From an expressive regulatory perspective,the vector systems employed by Pichia consist mainly between methanol-inducible types (e.g., pPIC9K) versus constitutive types (e.g., pGAPαA). Methanol-inducible carriers utilize strong promoter AOX1 activated under methanol induction achieving high-level expressions whereas constitutive carriers employ glyceraldehyde-3-phosphate dehydrogenase (GAP) promoters enabling continuous target protein expressions without induction requirements.
